Hannes Snellman Counsel to DevCo in Its Strategic Capital Raise Resulting in EUR 616 Million of Total Commitments for Medix Biochemica

Hannes Snellman acted as counsel to DevCo Partners Ltd in its strategic capital raise resulting in EUR 616 million of total commitments for its long-term single asset investment vehicle for Medix Biochemica. Medix Biochemica is a leading independent provider of critical biological raw material products for the in vitro diagnostics industry worldwide. The transaction, as part of which circa EUR 300 million of new investments were raised, provides DevCo with significant additional capital for continued support of the long-term growth strategy of Medix Biochemica.

Hannes Snellman’s core advisory team comprised Erik Stenman, Emmi Kantola, and Santeri Jääskeläinen (Private Equity) as well as Markus Bremer and Pauliina Sutinen (Finance).